Keywords: فاکتور V لیدن; Oral contraceptives; Glucocorticosteroid; Autoimmune disease; Factor V Leiden; Stroke;
مقالات ISI فاکتور V لیدن (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: فاکتور V لیدن; CVT; cerebral venous thrombosis; PAI-1; plasminogen activator inhibitor â 1; PC; protein C; PS; protein S; AT; antithrombin III; FVL; Factor V Leiden; tPA; tissue plasminogen activator; PLG; plasminogen; A2-AP; alpha-2-antiplasmin; APLA; antiphospholip
Keywords: فاکتور V لیدن; Thrombophilia; Hypercoagulable; Factor V Leiden; Protein C; Protein S;
Keywords: فاکتور V لیدن; factor V Leiden mutation; hypercoagulable state; hyperhomocysteinemia; livedoid vasculopathy; protein C deficiency; protein S deficiency; thrombophilia; thrombosis; ulcers; warfarin necrosis; AB; atrophie blanche; APC; activated protein C; APS; antiphosph
Keywords: فاکتور V لیدن; retinal vein occlusion; serous choroidal detachment; macular edema; lymphoplasmacytic leukemia; polycythemia; prothrombin G20210A; factor V Leiden; hyperhomocysteinemia; indocyanine green angiography
Keywords: فاکتور V لیدن; Venous thromboembolism; Thrombosis; Pregnancy; Factor V Leiden; Prothrombin; Meta-analysis
Keywords: فاکتور V لیدن; Prothrombotic; Hypercoagulable; Stroke; Factor V Leiden; Prothrombin mutation; Antithrombin III; Antiphospholipid antibodies; Homocysteine;
Keywords: فاکتور V لیدن; Pulmonary embolism; Factor V Leiden; Prothrombin G20210A; Methylenetetrahydrofolate reductase (MTHFR) C677T; Gene mutation
Keywords: فاکتور V لیدن; CI; confidence interval; OR; odds ratio; DVT; deep venous thrombosis; PE; pulmonary embolism; THA; total hip arthroplasty; TKA; total knee arthroplasty; FLV; factor V Leiden; APC; activated protein C; VTE; venous thrombus embolism; STREGA; strengthening t
Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study
Keywords: فاکتور V لیدن; CUS; compression ultrasonography; DVT; deep vein thrombosis; FVL; Factor V Leiden; OAT; oral anticoagulant therapy; PE; pulmonary embolism; PGM; prothrombin gene mutation; PVO; percentage of vascular obstruction; RVO; residual vein obstruction; VTE; venou
Fat mass and obesity-associated gene rs9939609 polymorphism is a potential biomarker of recurrent venous thromboembolism in male but not in female patients
Keywords: فاکتور V لیدن; A; adenine; BMI; body mass index; CT; computed tomography; CI; confidence interval; CRP; C-reactive protein; DVT; deep vein thrombosis; DNA; deoxyribonucleic acid; FTO; fat mass and obesity-associated gene; FVL; factor V Leiden; HR; hazard ratio; kIU; kil
High prevalence of factor V Leiden and prothrombin G20101A mutations in Kashmiri patients with venous thromboembolism
Keywords: فاکتور V لیدن; FVL; factor V Leiden; MTHFR; methylene tetrahydrofolate reductase; ARMS; amplification-refractory mutation system; PCR; polymerase chain reaction; RFLP; restriction fragment length polymorphism; VTE; venous thromboembolism; DVT; deep venous thrombosis; PT
Genetics of Hypercoagulable and Hypocoagulable States
Keywords: فاکتور V لیدن; Factor V Leiden; Prothrombin gene mutation; Protein C and S deficiencies; Antithrombin deficiency; Antiphospholipid syndrome; von Willebrand disease; Hemophilia;
Genetics of immunoglobulin-A vasculitis (Henoch-Schönlein purpura): An updated review
Keywords: فاکتور V لیدن; AAV; antineutrophil cytoplasmic antibody associated vasculitis; ACE; angiotensin-converting enzyme; Agt; angiotensin; ANCA; antineutrophil cytoplasmic antibody; AT1R; angiotensin II receptor type 1; AT2R; angiotensin II receptor type 2; CCL2; chemokine C-
PAPERSAnticoagulants to prevent recurrent placenta-mediated pregnancy complications: Is it time to put the needles away?
Keywords: فاکتور V لیدن; Low-molecular-weight heparin; Pre-eclampsia; Placental abruption; Pregnancy loss; Small-for-gestational age; Thrombophilia; LMWH; low-molecular-weight heparin; SGA; small-for-gestational age; FVL; Factor V Leiden; PGM; prothrombin gene mutation; ASA; aspi
PAPERSGender-related differences in the outcome of patients with venous thromboembolism and thrombophilia
Keywords: فاکتور V لیدن; Gender; Venous thromboembolism; Thrombophilia; Factor V Leiden; Prothrombin 20210Â G-A polymorphism;
Opinion paperA genetic study of Factor V Leiden (G1691A) mutation in young ischemic strokes with large vessel disease in a South Indian population
Keywords: فاکتور V لیدن; Factor V Leiden; Large vessel infarct; Heterozygous mutation;
Do incident and recurrent venous thromboembolism risks truly differ between heterozygous and homozygous Factor V Leiden carriers? A retrospective cohort study
Keywords: فاکتور V لیدن; APC, Activated protein C; FVa, Factor FVa; PCR, Polymerase chain reaction; PE, Pulmonary embolism; VTE, Venous thromboembolismActivated protein C resistance; Factor V Leiden; Thrombophilia; Venous thrombosis; Pulmonary embolism
Association Between Factor V Leiden Mutation, Small for Gestational Age, and Preterm Birth: A Systematic Review and Meta-Analysis
Keywords: فاکتور V لیدن; Preterm birth; intrauterine growth restriction; thrombophilia; systematic review; meta-analysis; FVL; factor V Leiden; NOS; Newcastle-Ottawa Scale;
Prothrombin G20210A mutation is associated with recurrent pregnancy loss: A systematic review and meta-analysis update
Keywords: فاکتور V لیدن; RPL; Recurrent pregnancy loss; OR; Odds ratio; CI; Confidence interval; IT; Inherited thrombophilia; FVL; Factor V Leiden; MTHFR; Methylenetetrahydrofolate reductase; HWE; Hardy-Weinberg Equilibrium; PAR; Population-attributable risk; RCOG; Royal College
Hypertension intracrânienne idiopathique et mutation du facteur V de Leiden
Keywords: فاکتور V لیدن; Hypertension intracrânienne idiopathique; Résistance à la protéine C activée; Facteur V Leiden; Thrombose; Idiopathic intracranial hypertension; Activated protein C resistance; Factor V Leiden; Thrombosis;
Possible incorrect genotyping of heterozygous factor V Leiden and Prothrombin 20210 gene mutations by the GeneXpert assay
Keywords: فاکتور V لیدن; GeneXpert; Inherited thrombophilia; Factor V Leiden; GPRO mutation
The association between Factor V Leiden with the presence and severity of coronary artery disease
Keywords: فاکتور V لیدن; Coronary artery disease; Factor V Leiden; G1691A variant; Coronary angiography;
Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: A meta-analysis
Keywords: فاکتور V لیدن; CI; confidence interval; OR; odds ratio; HWE; Hardy-Weinberg equilibrium; VTE; venous thromboembolism; DVT; deep venous thrombosis; PE; pulmonary embolism; FVL; factor V Leiden; HT; hormone therapy; APL; antiphospholipid antibody syndrome; Venous thromb
Increased activation of blood coagulation in pregnant women with the Factor V Leiden mutation
Keywords: فاکتور V لیدن; APC; activated protein C; c.s; caesarean section; CV; coefficient of variation; DIC; disseminated intravascular coagulation; DVT; deep vein thrombosis; ELISA; enzyme-linked immunosorbent assay; FVL; Factor V Leiden; F1Â +Â 2; prothrombin fragments 1Â +Â 2
Anticoagulant factor V: Factors affecting the integration of novel scientific discoveries into the broader framework
Keywords: فاکتور V لیدن; Factor V; Factor V Leiden; Thrombophilia; Coagulation cascade; Anticoagulant;
Associations of Coagulation Factor V Leiden and Prothrombin G20210A Mutations With Budd-Chiari Syndrome and Portal Vein Thrombosis: A Systematic Review and Meta-analysis
Keywords: فاکتور V لیدن; Genetic; Venous Thromboembolism; Risk Factor; Blood; AASLD; American Association for the Study of Liver Diseases; BCS; Budd-Chiari syndrome; CI; confidence interval; DVT; deep vein thrombosis; FVL; factor V Leiden; OR; odds ratio; PVT; portal vein throm
Is thrombin generation at the time of an acute thromboembolic episode a predictor of recurrence? The LInköping Study on Thrombosis (LIST) - A 7-year follow-up
Keywords: فاکتور V لیدن; DVT; Deep Vein Thrombosis; PE; Pulmonary Embolism; VTE; Venous Thrombo Embolism; OAC; Oral Anticoagulants; FV Leiden; Factor V Leiden; APC; Activated Protein C; TGT; Thrombin Generation Test; TG; Thrombin Generation; LIST; LInköping Study on Thrombosis;
Factor V Leiden and Ischemic Stroke Risk: The Genetics of Early Onset Stroke (GEOS) Study
Keywords: فاکتور V لیدن; Factor V Leiden; risk factor; stroke; young adults
Regular ArticleUnexplained infertility: Association with inherited thrombophilia
Keywords: فاکتور V لیدن; PC; protein C; PS; protein S; AT; antithrombin; FVL; Factor V Leiden; PT; prothrombin gene; Male; Female and unexplained infertility; Inherited thrombophilia; Prothrombin gene mutation;
Relation between maternal thrombophilia and stillbirth according to causes/associated conditions of death
Keywords: فاکتور V لیدن; Factor V Leiden; Factor II mutation; Acquired thrombophilia; Stillbirth; Placenta vascular disorders
Deep venous thromboembolism after a trauma in a football player double heterozygous for factor V Leiden and prothrombin G20210A mutation: The role of genetic testing in sport*
Keywords: فاکتور V لیدن; Deep vein thrombosis; Inherited thrombotic mutations; Factor V Leiden; Prothrombin G20210A mutation;
Variable plasma levels of Factor V Leiden correlate with circulating platelet microparticles in carriers of Factor V Leiden
Keywords: فاکتور V لیدن; Factor V Leiden; APC resistance; Circulating platelet microparticles; Venous thromboembolism;
Patterns of placental pathology in preterm infants with a periventricular haemorrhagic infarction: Association with time of onset and clinical presentation
Keywords: فاکتور V لیدن; Periventricular haemorrhagic infarction; Placenta; Factor V Leiden; Placental fetal thrombosis; PVHI; periventricular haemorrhagic infarction; cPVL; cystic periventricular leukomalacia; GA; gestational age; GMH-IVH; germinal matrix haemorrhage-intrave
Pregnancy-related venous thromboembolism: Risk and the effect of thromboprophylaxis
Keywords: فاکتور V لیدن; VTE; venous thromboembolism; DVT; deep vein thrombosis; PE; pulmonary embolism; FV Leiden; factor V Leiden; APLA; antiphospholipid antibody; APS; antiphospholipid syndrome; HIT; heparin-induced thrombocytopenia; UFH; unfractionated heparin; LMWH; low-mole
Résistance à la protéine C activée et facteur V Leiden : intérêt clinique
Keywords: فاکتور V لیدن; Résistance à la protéine C activée; Facteur V Leiden; Thromboses; Thrombophilie; Pertes fœtalesActivated protein C resistance; Factor V Leiden; Thrombosis; Thrombophilia; Foetal loss
Hemodialysis vascular access thrombosis: The role of factor V Leiden, prothrombin gene mutation and ABO blood groups
Keywords: فاکتور V لیدن; Hemodialysis; Thrombosis; Factor V Leiden; Prothrombin gene mutation; Vascular access; ABO blood groups;
Prothrombin and risk of venous thromboembolism, ischemic heart disease and ischemic cerebrovascular disease in the general population
Keywords: فاکتور V لیدن; Prothormbin G20210A; Venous thromboembolism; Ischemic heart disease; Ischemic cerebrovascular disease; Factor V Leiden;
Circulating microparticles are elevated in carriers of Factor V Leiden
Keywords: فاکتور V لیدن; Microparticles; Thrombosis; Factor V Leiden; Heterozygotes; DVT
Thrombotic complications in children with haematologic malignacies
Keywords: فاکتور V لیدن; Children; Thrombosis; Acute leukemia; Essential Thrombocytosis; Polycythemia Vera; AIEOP; Italian Association for Paediatric Haematology Oncology; ALL; Acute lymphoblastic leukemia; AML; Acute myeloid leukemia; CNS; Central nervous system; CVC; Central ve
Prophylactic plasma levels of the low molecular weight heparin nadroparin does not affect colon cancer tumor development in mouse liver
Keywords: فاکتور V لیدن; FVL; Factor V Leiden; FVIII; Factor VIII; LMWH; Low molecular weight heparin; TF; Tissue factor; MCA-38 colon carcinoma; low molecular weight heparin; fibrinogen;
Clinical characteristics of patients with factor V Leiden or prothrombin G20210A and a first episode of venous thromboembolism. Findings from the RIETE Registry
Keywords: فاکتور V لیدن; Thrombophilia; Factor V Leiden; Prothrombin G20210A; Venous thromboembolism; Asymptomatic carriers
Antiphospholipid antibody syndrome causing acute myocardial infarction in a young adult
Keywords: فاکتور V لیدن; Myocardial infarction; Antiphospholipid antibody syndrome; Factor V Leiden; Hypercoagulable state; Anticoagulation; Young adult;
Thrombophilic risk factors for placental stillbirth
Keywords: فاکتور V لیدن; IUFD; Stillbirth; Placental stillbirth; Thrombophilia; Factor V Leiden; Prothrombin G20210A mutation
Antiphospholipid antibodies and pregnancy outcomes in women heterozygous for Factor V Leiden
Keywords: فاکتور V لیدن; anticardiolipin, anticardiolipin antibodies; aPL, antiphospholipid; β2 GPI, β2 glycoprotein I; FVL, Factor V Leiden; LAC, lupus anticoagulant; preeclampsia, pre-eclampsia; SGA, small for gestational ageAntiphospholipid antibodies; Factor V Leiden; Preecla
Factor V Leiden mutation and pregnancy-related complications
Keywords: فاکتور V لیدن; blood loss; factor V Leiden; obstetric complications; pregnancy; venous thromboembolism;
Screening, Testing, or Personalized Medicine: Where do Inherited Thrombophilias Fit Best?
Keywords: فاکتور V لیدن; Thrombophilia; Genetic screening; Pregnancy; Adverse pregnancy outcomes; Factor V Leiden; Prothrombin G20210A;
Evaluation of the Nanosphere Verigene® System and the Verigene®F5/F2/MTHFR Nucleic Acid Tests
Keywords: فاکتور V لیدن; Genotyping; Mutation; Molecular diagnostics; Factor V Leiden; Factor II; Prothrombin; MTHFR
Maternal thrombophilia and the risk of recurrence of preeclampsia
Keywords: فاکتور V لیدن; factor V Leiden; heritable thrombophilia; preeclampsia; prothrombin mutation; thrombophilia;
Clinical factors such as B-type natriuretic peptide link to factor VII, endothelial NO synthase and estrogen receptor α polymorphism in elderly women
Keywords: فاکتور V لیدن; Natriuretic peptide; Estrogen receptor; Factor V Leiden; Endothelial nitric oxide synthase; Single nucleotide polymorphism; Thrombosis